NL-OMON52034招募中不适用
Multicenter Randomized Clinical Trial to Assess the Effect of Active versus Passive Recharge Burst Spinal Cord Stimulation on Pain Relief in Failed Back Surgery - Active vs. passibe burst in FBSS
Rijnstate Ziekenhuis0 个研究点目标入组 94 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 94
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64(—)
入选标准
- •Subject of either gender between 18 and 65 years of age
- •Al least moderate level of catastrophizing as measured with the Pain
- •catastrophizing score (PCS) of at least 20.[23]
- •History consistent with FBSS of at least 6 months
- •Neurologic exam without marked motor deficit.
- •Low Back Pain or leg pain intensity should be 5 or higher measured with the
- •11-box NRS 0-10
- •Meets all the inclusion criteria for the implantation of a neurostimulation
- •system as typically utilized in the study center. PM: depression is not an
- •exclusion criteria
- •Subject has been screened by a multi-disciplinary panel including a
- •psychologist and deemed suitable for implantation
- •Subject is able and willing to comply with the follow-up schedule and protocol
- •Subject is able to provide written informed consent
排除标准
- •Female subject of childbearing potential is pregnant/nursing or plans to
- •become pregnant during the course of the study
- •Escalating or changing pain condition within the past month as evidenced by
- •investigator examination
- •BMI >=35
- •Subject has had injection therapy or radiofrequency treatment for their low
- •back pain within the past 3 months
- •Subject currently has an active implantable device including ICD, pacemaker,
- •spinal cord stimulator or intrathecal drug pump
- •Subject is unable to operate the device
- •Severe disc degeneration at the affected level as evidenced by >50% disc
- •height loss on plain anteroposterior and lateral lumbar radiographs or CT/MRI.
- •Moderate to severe spinal stenosis due to osteophyte and/or ligamentous
- •overgrowth as evidenced by MRI or CT in the previous 6 months
- •Moderate to severe endplate degenerative changes at the affected levels
- •Grade 1-2 spondylolisthesis
- •Previous Neurostimulation therapy
研究者
相似试验
进行中(未招募)
1 期
Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19EUCTR2020-001530-35-ESFundación para la Investigación Biomédica del Hospital La Paz (FIBHULP)450
进行中(未招募)
1 期
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for PatientsWith Acute Ischemic Stroke Due to Tandem LesioAcute Ischemic StrokeMedDRA version: 22.1Level: LLTClassification code: 10055221Term: Ischemic stroke Class: 10029205MedDRA version: 20.0Level: SOCClassification code: 10047065Term: Vascular disorders Class: 12MedDRA version: 20.0Level: HLGTClassification code: 10003216Term: Arteriosclerosis stenosis vascular insufficiency and necrosis Class: 10047065MedDRA version: 22.1Level: PTClassification code: 10061256Term: Ischaemic stroke Class: 100000004852MedDRA version: 20.0Level: HLTClassification code: 10008192Term: Cerebrovascular and spinal necrosis and vascular insufficiency Class: 10047065CTIS2023-508454-26-00Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla240
招募中
不适用
Prospective Randomized Multicenter Trial to Assess the Feasibility of a Structured Physical Exercise Training and Mediterranean-style Diet in Women With BRCA1/2MutationsC50C56Malignant neoplasm of breastMalignant neoplasm of ovaryDRKS00005736Klinikum rechts der Isar der TU München, Frauenklinik60
已完成
3 期
Multicenter Randomized Controlled Trial to Assess the Necessity of Second-look Endoscopy after Endoscopic Submucosal Dissection (ESD) for gastric neoplasms: the SAFE studyearly gastric cancer/gastric adenomaJPRN-UMIN000007170Graduate School of Medicine, University of Tokyo250
进行中(未招募)
不适用
Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinomaColorectal cancerEUCTR2015-001801-15-ESFIBICO
